TRPV1 and Alzheimer disease: We also reported that pharmacological activation of TRPV1 by its agonist CAP could rescue the deficits of spatial learning and memory in the APP23/PS45 mice, indicating that activation of TRPV1 may serve as a potential strategy for AD treatment.